Top Banner
Presented by: Karen Ginsbury For IFF, Denmark March 2012
41
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Presented by: Karen GinsburyFor IFF, DenmarkMarch 2012

Page 2: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

EU GMPs Part 1 – Medicinal Products (finished Product)1. Quality Management (Quality Management

System)Updated to incorporate ICH Q10 concepts

2. Personnel3. Facilities and Equipment4. Documentation5. Production (and packaging)6. Quality Control (includes QA and QC)7. Contract Manufacture and Analysis

(outsourced operations)8. Complaints and recalls9. Self - inspection

Page 3: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Course ObjectiveUpdate with current regulationsUpdate on regulations and guidance in the

makingProactively plan improvements to the quality

management system to:Reduce deviationsReduce non conformancesEnhance complianceEnsure positive inspection outcomes.

Page 4: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Special Requests? Expectations?

????

Page 5: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Some tips before we get goingCheck out:FDA what’s newEMA what’s newFDA Guidance agenda 2011 (2012 not yet

out)EMA IWG workplan 2012And don’t forget to keep checking the websites

Page 6: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

FDA – what’s newhttp://www.fda.gov/Drugs/NewsEvents/ucm130958.htm

Page 7: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

EMA - What’s newhttp://www.ema.europa.eu/ema/index.jsp?

curl=pages/news_and_events/landing/whats_new.jsp&mid=WC0b01ac058004d5c4&jsenabled=true

Page 8: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

FDA Guidance Agenda 2011

Page 9: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

EMA IWG Workplan 2012http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/10/WC500004875.pdf

Page 10: Presented by: Karen Ginsbury For IFF, Denmark March 2012.
Page 11: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

GMPs

Page 12: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

GMPs

Page 13: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

GDP

Page 14: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Falsified Medicines Legislation and Delegated Act

Page 15: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm121568.htm

Page 16: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079645.pdf

Page 17: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079645.pdf

Page 18: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079645.pdf

Page 19: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/11/news_detail_001392.jsp&mid=WC0b01ac058004d5c1

Page 20: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/landing/human_medicines_regulatory.jsp&mid=WC0b01ac058001ff89

Page 21: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000081.jsp&mid=WC0b01ac0580027546

Page 22: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Who else is out thereOther players:

PIC/sWHOICHUSPISO

Page 23: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.picscheme.org/

Page 24: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

http://www.picscheme.org/

Page 25: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

PIC/s Guidances

http://www.picscheme.org/publication.php?id=4GMP guide

http://www.picscheme.org/publication.php?id=14Aide memoires

http://www.picscheme.org/publication.php?id=8Guidance Documents

Page 26: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

PIC/s Guidances

Page 27: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

PIC/s Guidances

Page 28: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

WHO

Page 29: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

WHO

Page 30: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

WHO

Page 31: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

PCI Pharmaceutical Consulting Israel Ltd

What is ICHThe International Conference

OnHarmonisation of

Technical RequirementsFor

Registration of Pharmaceuticalsfor Human Use

Page 32: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

PCI Pharmaceutical Consulting Israel Ltd

ICH MembersRegulators and industry as equal partners in

scientific and technical discussions of testing procedures required to ensure and assess safety, quality and efficacy of medicines

Regulators:EU (EMEA), FDA, MHLW (Japan)

Industry (trade organizations): EFPIA, PhRMA, JPMA

Observers: WHO, EFTA (Norway, Switzerland...), and (Health) Canada

Page 33: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

PCI Pharmaceutical Consulting Israel Ltd

http://www.ich.org/cache/compo/276-254-1.html

Page 34: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

ICH Q8, 9, 10 vs FDA Quality System Guidance

Pharmaceutical DevelopmentQuality Risk ManagementPharmaceutical Quality System

Page 35: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

ICH Q8, 9, 10 vs FDA Quality System Guidance

Page 36: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

ICH Q8, 9, 10 vs FDA Quality System GuidanceThe guidance is similar in structure to Q10

but far more detailed and more tied in with the GMPs

For those intimately involved in establishing, maintaining and continually improving a QMS that meets US FDA requirements and expectations – it is worth a read

Page 37: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Latest guidance is Q11Development and manufacture of drug

substance (API)

Available for download

Page 38: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

USPGeneral chaptersChapters below <999> are mandatoryChapters above 1000 and over are NOT mandatorySo chapter 11 on reference standards is mandatoryWhereas chapter <1117> on Good Microbiological

Laboratory Practice is NOT mandatoryBut general chapters can be a useful source of

informationAnd USP has a vendor qualifcation program…

Page 39: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Ph. Eur. and EDQM (European Directorate on Quality of Medicine)

Certify starting materials in a formal qualification and inspection program

Includes BSE / TSE certificates

Page 40: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

ISOInternational Standards OrganisationVoluntary standardsICH Q10 modelled on ISO 9001:2008

Page 41: Presented by: Karen Ginsbury For IFF, Denmark March 2012.

Questions at this point?